IRON Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
IRON Financial's BMY Position: Q3 2026 in Review
IRON Financial reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q3 2026, selling an estimated $8.03K and leaving 3,822 shares worth $239K. The position accounts for 0.1% of the portfolio, ranked #123.
IRON Financial first reported a position in BMY in Q1 2023 and has held it in 9 quarters since. The position peaked at $734K in Q1 2024. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- IRON Financial held 3,822 shares of Bristol-Myers Squibb worth $239K as of Q3 2026.
- IRON Financial sold 127 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.03K.
- Bristol-Myers Squibb made up 0.1% of IRON Financial's portfolio in Q3 2026, its #123 holding.
- IRON Financial first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 9 quarters since.
- IRON Financial's Bristol-Myers Squibb position peaked at $734K in Q1 2024.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on IRON Financial's 13F filing for Q3 2026, filed 23 Oct 2026.